AI assistant
IMUGENE LIMITED — Capital/Financing Update 2003
May 1, 2003
65124_rns_2003-05-01_c4c89200-b1ae-4f50-bfe1-0cdd1a58f691.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002.
Name of entity
IMUGENE LIMITED
$ABN$
99 009 179 551
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
$\pmb{\mathsf{I}}$ +Class of +securities issued or to be issued
Ordinary shares
- $\overline{2}$ Number of *securities issued or to be 330,525 issued (if known) or maximum number which may be issued
- 3 Principal terms of the "securities (eg, if options, exercise price and expiry date; if partly paid "securities, the amount outstanding and due dates for payment; if "convertible securities, the conversion price and dates for conversion)
Fully paid ordinary shares
+ See chapter 19 for defined terms.
| 4 | Do the "securities rank equally in all respects from the date of allotment with an existing class of quoted securities? If the additional securities do not rank equally, please state: |
Yes | |
|---|---|---|---|
| the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment |
|||
| • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment |
|||
| 5 | Issue price or consideration | Consideration for the acquisition of 107,165 Shares and Limited. |
90,304 Options in VectoGen |
| 6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) |
of issued capital in Vectogen) and the Options held by Australian Pork Limited. |
Acquisition of VectoGen Limited Shares (1.2% |
| 7 | Dates of entering "securities into uncertificated holdings or despatch of certificates |
2 May 2003 | |
| Number | $^{\circ}$ Class | ||
| 8 | Number and "class of all "securities" quoted on ASX (including the securities in clause 2 if applicable) |
77,693,859 | Ordinary shares |
$\pm$ See chapter 19 for defined terms.
| -0 | Number and + class of all + securities |
|---|---|
| not quoted on ASX (including the | |
| securities in clause 2 if applicable) |
| Number | *Class |
|---|---|
| 4,313,340 | Options exercisable at |
| $11.25$ cents | |
| 4.633,333 | Performance Options |
$10\,$ Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)
Not Applicable
Part 2- Bonus issue or pro rata issue
| $\mathbf{H}$ | Is security holder approval required? | Not Applicable |
|---|---|---|
| 12 | renounceable or non- Is the issue renounceable? |
Not Applicable |
| 13 | Ratio in which the "securities will be offered |
Not Applicable |
| 4 | " Class of " securities to which the offer relates |
Not Applicable |
| 15 | Record date to determine entitlements | Not Applicable |
| 16 | Will holdings on different registers (or subregisters) be aggregated fог calculating entitlements? |
Not Applicable |
| 17 | Policy for deciding entitlements in relation to fractions |
Not Applicable |
| 18 | Names of countries in which the entity has "security holders who will not be sent new issue documents Note: Security holders must be told how their entitiements are to be dealt with. |
Not Applicable |
| Cross reference: rule 7.7. | ||
| 19 | Closing date for receipt of acceptances or renunciations |
Not Applicable |
$\pm$ See chapter 19 for defined terms.
| 20. | Names of any underwriters | Not Applicable |
|---|---|---|
| 21 | Amount of any underwriting fee or commission |
Not Applicable |
| 22. | Names of any brokers to the issue | Not Applicable |
| 23 | Fee or commission payable to the broker to the issue |
Not Applicable |
| 24 | Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of 'security holders |
Not Applicable |
| 25. | If the issue is contingent on "security" holders' approval, the date of the meeting |
Not Applicable |
| 26 | Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled |
Not Applicable |
| 27. | If the entity has issued op tions, and the holders entitle option terms ťΟ participate on exercise, the date on which notices will be sent to option holders |
Not Applicable |
| 28. | Date rights trading will begin (if applicable) |
Not Applicable |
| 29 | will end $(ii$ trading rights Date applicable) |
Not Applicable |
| 30 | How do security holders sell their entitlements in full through a broker? |
Not Applicable |
| 31 | How do * security holders sell part of their entitlements through a broker and accept for the balance? |
Not Applicable |
$\pm$ See chapter 19 for defined terms.
32 How do "security holders dispose of their entitlements (except by sale through a broker)?
33 Despatch date Not Applicable
Not Applicable
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of securities (tick one)
$(b)$
$(a)$ Securities described in Part 1
| All other securities | ||
|---|---|---|
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
(If the additional securities do not form a new class, go to $43$ )
| Tick to indicate you are providing the information or | |||||
|---|---|---|---|---|---|
| documents |
| 35 If the $\vec{ }$ securities are $\vec{ }$ equity securities, the names of the 20 largest holders of the additional $\vec{ }$ securities, and the number and percentage of additional $\vec{ }$ securities held by those holders | |
|---|---|
| 36 If the $\overline{\phantom{a}}$ securities are $\overline{\phantom{a}}$ equity securities, a distribution schedule of the additional $\overline{\phantom{a}}$ securities setting out the number of holders in the categories $1 - 1.000$ 1.001 - 5.000 |
| 1,001 = 2,000 |
|---|
| 5,001 - 10,000 |
| 10,001 - 100,000 |
| 100,001 and over |
37
A copy of any trust deed for the additional "securities
(now go to 43)
+ See chapter 19 for defined terms.
Entities that have ticked box 34(b)
| 38 | which Number οf securities for * quotation is sought |
Not Applicable | |
|---|---|---|---|
| 39. | Class of $\beta$ securities for which quotation is sought |
Not Applicable | |
| 40 | Do the "securities rank equally in all respects from the date of allotment with an existing "class of quoted "securities? |
Not Applicable | |
| If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of |
|||
| a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the |
|||
| next dividend, distribution or interest payment |
|||
| 41 | Reason for request for quotation now | Not Applicable | |
| Example: In the case of restricted securities, end of restriction period |
|||
| (if issued upon conversion of another security, clearly identify that other security) |
|||
| Number | $^{\circ}$ Class | ||
| 42 | Number and "class of all "securities" quoted on ASX (including the securities in clause 38) |
Not Applicable | |
$(now go to 43)$
$\pm$ See chapter 19 for defined terms.
All entities
Fees
| Cheque attached |
|---|
| Electronic payment made Note: Payment may be made electronically if Appendix 3B is given to ASX electronically at the same time. |
| Periodic payment as agreed with the home branch has been arranged Note: Arrangements can bemade for employee incentive schemes that involve frequent issues of securities. |
Quotation agreement
- $\mathbf{I}$ "Quotation of our additional "securities is in ASX's absolute discretion. ASX may quote the "securities on any conditions it decides.
- $\overline{2}$ We warrant the following to ASX.
- The issue of the "securities to be quoted complies with the law and is not for $\bullet$ an illegal purpose.
- There is no reason why those "securities should not be granted" quotation. $\bullet$
- An offer of the "securities for sale within 12 months after their issue will not $\bullet$ require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to elve this warranty
- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any "securities to be quoted and that no-one has any right to return any "securities to be quoted under sections 737, 738 or 1016F of he Corporations Act at the time that we request that the 'securities be quoted.
- We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the "securities to be quoted, it has been provided at the time that we request that the "securities be quoted.
- If we are a trust, we warrant that no person has the right to return the securities to be quoted under section 1019B of the Corporations Act at the time that we request that the "securities be quoted.
+ See chapter 19 for defined terms.
- $\overline{\mathbf{3}}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
- $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before "quotation of the 'securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
| Sign here: | . . . | Date: 2 May 2003 |
|---|---|---|
| ( Director /Company secretary) |
MARK PEARCE Print name:
+ See chapter 19 for defined terms.